| 7901 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
68 |
| 7902 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
63 |
| 7903 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
57 |
| 7904 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
68 |
| 7905 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
56 |
| 7906 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
61 |
| 7907 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
55 |
| 7908 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
64 |
| 7909 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
64 |
| 7910 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
52 |
| 7911 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
55 |
| 7912 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
67 |
| 7913 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
49 |
| 7914 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
56 |
| 7915 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
47 |
| 7916 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
53 |
| 7917 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
58 |
| 7918 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
49 |
| 7919 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
69 |
| 7920 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
61 |
| 7921 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
54 |
| 7922 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
65 |
| 7923 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
48 |
| 7924 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
60 |
| 7925 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
56 |
| 7926 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
50 |
| 7927 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
73 |
| 7928 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
47 |
| 7929 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
67 |
| 7930 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
62 |
| 7931 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
61 |
| 7932 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
68 |
| 7933 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
65 |
| 7934 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
15 |
| 7935 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
52 |
| 7936 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
20 |
| 7937 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
60 |
| 7938 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
9 |
| 7939 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
61 |
| 7940 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
63 |
| 7941 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
15 |
| 7942 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
37 |
| 7943 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
59 |
| 7944 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
62 |
| 7945 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
58 |
| 7946 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
69 |
| 7947 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
66 |
| 7948 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
67 |
| 7949 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
57 |
| 7950 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome – Rcmd
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
32 |
| 7951 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome – Raeb
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
56 |
| 7952 |
Apheresis |
Allogeneic
|
Myelofibrosis
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
72 |
| 7953 |
Apheresis |
Allogeneic
|
Myelofibrosis
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
66 |
| 7954 |
Apheresis |
Allogeneic
|
Myelofibrosis
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
67 |
| 7955 |
Apheresis |
Allogeneic
|
Myeloma Multiplex
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
63 |
| 7956 |
Apheresis |
Allogeneic
|
Myeloma Multiplex
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
51 |
| 7957 |
Apheresis |
Allogeneic
|
Myeloma Multiplex
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
38 |
| 7958 |
Apheresis |
Allogeneic
|
Myeloproliferative Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
52 |
| 7959 |
Apheresis |
Allogeneic
|
Myeloproliferative Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
63 |
| 7960 |
Apheresis |
Autologous
|
Neuroblastoma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
5 |
| 7961 |
Apheresis |
Allogeneic
|
No Data
|
no data
|
2016
|
Standard Therapy
|
Poland
|
45 |
| 7962 |
Apheresis |
Allogeneic
|
No Data
|
no data
|
2016
|
Standard Therapy
|
Poland
|
70 |
| 7963 |
Apheresis |
Allogeneic
|
No Data
|
no data
|
2016
|
Standard Therapy
|
Poland
|
43 |
| 7964 |
Apheresis |
Allogeneic
|
No Data
|
no data
|
2016
|
Standard Therapy
|
Poland
|
69 |
| 7965 |
Apheresis |
Allogeneic
|
No Data
|
no data
|
2016
|
Standard Therapy
|
Poland
|
28 |
| 7966 |
Apheresis |
Allogeneic
|
No Data
|
no data
|
2016
|
Standard Therapy
|
Poland
|
1 |
| 7967 |
Apheresis |
Allogeneic
|
No Data
|
no data
|
2016
|
Standard Therapy
|
Poland
|
30 |
| 7968 |
Apheresis |
Allogeneic
|
No Data
|
no data
|
2016
|
Standard Therapy
|
Poland
|
71 |
| 7969 |
Apheresis |
Allogeneic
|
No Data
|
no data
|
2016
|
Standard Therapy
|
Poland
|
58 |
| 7970 |
Apheresis |
Allogeneic
|
No Data
|
no data
|
2016
|
Standard Therapy
|
Poland
|
17 |
| 7971 |
Apheresis |
Allogeneic
|
No Data
|
no data
|
2016
|
Standard Therapy
|
Poland
|
59 |
| 7972 |
Apheresis |
Allogeneic
|
No Data
|
no data
|
2016
|
Standard Therapy
|
Poland
|
58 |
| 7973 |
Apheresis |
Allogeneic
|
No Data
|
no data
|
2016
|
Standard Therapy
|
Poland
|
55 |
| 7974 |
Apheresis |
Allogeneic
|
No Data
|
no data
|
2016
|
Standard Therapy
|
Poland
|
44 |
| 7975 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
38 |
| 7976 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
58 |
| 7977 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
32 |
| 7978 |
Apheresis |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
39 |
| 7979 |
Apheresis |
Autologous
|
Non-Hodgkin Lymphoma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
61 |
| 7980 |
Apheresis |
Autologous
|
Non-Hodgkin Lymphoma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
73 |
| 7981 |
Apheresis |
Autologous
|
Non-Hodgkin Lymphoma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
27 |
| 7982 |
Apheresis |
Autologous
|
Non-Hodgkin Lymphoma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
65 |
| 7983 |
Apheresis |
Autologous
|
Non-Hodgkin Lymphoma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
61 |
| 7984 |
Apheresis |
Allogeneic
|
Plasma Cell Disorder
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
47 |
| 7985 |
Apheresis |
Autologous
|
Plasmacytoma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
58 |
| 7986 |
Apheresis |
Autologous
|
Plasmacytoma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
68 |
| 7987 |
Apheresis |
Autologous
|
Plasmacytoma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
48 |
| 7988 |
Apheresis |
Autologous
|
Primary Central Nervous System Lymphoma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
62 |
| 7989 |
Apheresis |
Autologous
|
Primary Central Nervous System Lymphoma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
51 |
| 7990 |
Apheresis |
Autologous
|
Primary Central Nervous System Lymphoma
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
62 |
| 7991 |
Apheresis |
Allogeneic
|
Primary Immunodeficiency
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
5 |
| 7992 |
Apheresis |
Allogeneic
|
Primary Myelofibrosis
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
50 |
| 7993 |
Apheresis |
Allogeneic
|
Primary Myelofibrosis
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
67 |
| 7994 |
Apheresis |
Allogeneic
|
Primary Myelofibrosis
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
67 |
| 7995 |
Apheresis |
Allogeneic
|
Primary Myelofibrosis
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
56 |
| 7996 |
Apheresis |
Allogeneic
|
Primary Myelofibrosis
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
58 |
| 7997 |
Apheresis |
Allogeneic
|
Refractory Anemia With Excess Blasts
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
62 |
| 7998 |
Apheresis |
Allogeneic
|
Severe Aplastic Anemia / Amyloidosis
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
45 |
| 7999 |
Apheresis |
Allogeneic
|
Secondary Acute Myeloid Leukemia At Myeloproliferative Syndrome
|
Hematology
|
2016
|
Standard Therapy
|
Germany
|
28 |
| 8000 |
Apheresis |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2016
|
Standard Therapy
|
Poland
|
18 |